Piramal Pharma unveils its Sustainability Report FY21-22, articulating its ESG journey to accelerate the pace of integrating sustainability practices
/PRNewswire/ -- Piramal Pharma Limited (PPL) today unveiled its Sustainability Report FY21–22 to provide a view of its performance on Environment, Social, and...
Source: prnewswire.com